alternative cancer treatment

New Data on Innovation Commercialization by Cancer Researchers Hides Impact of Federal Research Spending on Economy
KANSAS CITY, Mo.----April 10, 2006--Federally funded university cancer researchers are contributing more to the nation's economy by commercializing their research at rates much higher than is currently being measured by federal and university officials, according to a new study funded by the Ewing Marion Kauffman Foundation.
Source: biz.yahoo.com

(AFX UK Focus) 2006-04-10 08:42 GMT: Novartis submits Glivec for treatment of rare cancer forms in US and Europe
ZURICH (AFX) - Novartis AG announced it has submitted applications in the US and Europe for Glivec as treatment for four rare types of cancer. The Swiss pharma group said it has filed for approval for three rare forms of blood disorder and a deep form of skin cancer, dermatofibrosarcoma protuberans.
Source: www.iii.co.uk

Panitumumab Significantly Improved Progression-Free Survival And Disease Control In Metastatic Colorectal Cancer
Amgen (Nasdaq:AMGN), the world's largest biotechnology company, today announced pivotal Phase 3 results demonstrating that panitumumab significantly improved progression-free survival and disease control (response rate and stable disease) compared to best supportive care (BSC) in metastatic colorectal cancer patients who had failed standard chemotherapy... click link for more info.
Source: www.medicalnewstoday.com

Jefferson Researchers Uncover Genetic Signature That Predicts Colon Cancer
Researchers at Jefferson Medical College in Philadelphia have uncovered a genetic "signature" that accurately identifies colon cancer--a key, they hope, to better understand how the cancer develops.Colon cancer may begin when processes that regulate adult stem cells in the colon go awry. A handful of stem cells lie in the bottom of tiny tube-like "crypts" in the epithelium (or lining) of the
Source: www.medicalnewstoday.com

Evogenix to develop anti-cancer antibody
Sydney-based drug company Evogenix has made an agreement with the University of Massachusetts Medical School to develop an anti-cancer antibody.
Source: au.biz.yahoo.com

Letter: Cancer Costs
By Moira Wales In all the debate about "exciting" new drugs being denied to cancer patients ("Cancer", 2 April), the criticism seems to be directed at the National Health Service and the National Institute for Clinical Excellence (Nice).
Source: www.redorbit.com

Yonkers Biotech Rolls Out Prostate Cancer Test
By Philippidis, Alex A Yonkers biotechnology company is gearing up to compete with some of the nation's largest pharmaceutical giants in the budding market for selfscreening tests that detect prostate cancer - a test that could be applied someday to other forms of the disease.
Source: www.redorbit.com

Green Tea Prevents Prostate Cancer in High-Risk Men
WEDNESDAY, April 20 (HealthDay News) -- A supplement containing antioxidants from green tea was 90 percent effective in preventing prostate cancer in men at high risk for the disease.
Source: www.healthcentral.com

Alchemia to develop new cancer therapy
Australian drug company Alchemia has been awarded a $2 million grant by the Queensland government to develop a new cancer therapy.
Source: au.biz.yahoo.com